Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 17/20 | 0.74 |
| ▸ | TAS1R1 | Q7RTX1 | 17/20 | 0.74 |
| ▸ | CTSS | P25774 | 1/20 | 0.57 |
| ▸ | CTSK | P43235 | 1/20 | 0.57 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4197744 | 1.00 | TAS1R3 (0.74) | TAS1R3TAS1R1CTSSCTSKBCL2L1 | |
| SCHEMBL4197741 | 1.00 | TAS1R3 (0.74) | TAS1R3TAS1R1CTSSCTSKBCL2L1 | |
| SCHEMBL25496208 | 0.90 | TAS1R3 (0.61) | TAS1R3TAS1R1CTSSCTSK | |
| SCHEMBL7513867 | 0.88 | TAS1R3 (0.71) | TAS1R3TAS1R1BCL2L1 | |
| SCHEMBL26814846 | 0.87 | TAS1R3 (0.69) | TAS1R3TAS1R1CTSSCTSKBCL2L1 | |
| SCHEMBL6241209 | 0.86 | TAS1R3 (0.68) | TAS1R3TAS1R1CTSSCTSK | |
| SCHEMBL10407750 | 0.86 | TAS1R3 (0.68) | TAS1R3TAS1R1CTSSCTSK | |
| SCHEMBL4195344 | 0.85 | TAS1R3 (1.00) | TAS1R3TAS1R1 | |
| SCHEMBL4195341 | 0.85 | TAS1R3 (1.00) | TAS1R3TAS1R1 | |
| SCHEMBL4160513 | 0.84 | CA2 (0.68) | TAS1R3TAS1R1CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250024871-A1 | AMIDE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH INCORPORATED (US) | 2025-01-23 | — | — | US | disclosed |
| WO-2023091315-A2 | AMIDE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH INCORPORATED (US) | 2023-05-25 | — | — | WO | disclosed |